- Home
- YIBO vs INZY Comparison
YIBO vs INZY Comparison
Compare YIBO & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YIBO
- INZY
- Stock Information
- Founded
- YIBO 2011
- INZY 2015
- Country
- YIBO China
- INZY United States
- Employees
- YIBO N/A
- INZY N/A
- Industry
- YIBO
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- YIBO
- INZY Health Care
- Exchange
- YIBO NYSE
- INZY Nasdaq
- Market Cap
- YIBO 185.8M
- INZY 188.2M
- IPO Year
- YIBO 2024
- INZY 2020
- Fundamental
- Price
- YIBO $3.36
- INZY $1.35
- Analyst Decision
- YIBO
- INZY Strong Buy
- Analyst Count
- YIBO 0
- INZY 8
- Target Price
- YIBO N/A
- INZY $17.75
- AVG Volume (30 Days)
- YIBO 9.1K
- INZY 770.8K
- Earning Date
- YIBO 09-13-2024
- INZY 03-11-2025
- Dividend Yield
- YIBO N/A
- INZY N/A
- EPS Growth
- YIBO N/A
- INZY N/A
- EPS
- YIBO 0.17
- INZY N/A
- Revenue
- YIBO $153,281,000.00
- INZY N/A
- Revenue This Year
- YIBO N/A
- INZY N/A
- Revenue Next Year
- YIBO N/A
- INZY N/A
- P/E Ratio
- YIBO $18.81
- INZY N/A
- Revenue Growth
- YIBO 5.90
- INZY N/A
- 52 Week Low
- YIBO $1.80
- INZY $1.32
- 52 Week High
- YIBO $7.83
- INZY $7.80
- Technical
- Relative Strength Index (RSI)
- YIBO 49.04
- INZY 20.16
- Support Level
- YIBO $2.79
- INZY $1.32
- Resistance Level
- YIBO $3.63
- INZY $3.18
- Average True Range (ATR)
- YIBO 0.36
- INZY 0.26
- MACD
- YIBO -0.01
- INZY -0.13
- Stochastic Oscillator
- YIBO 58.16
- INZY 1.61
About YIBO PLANET IMAGE INTERNATIONAL LIMITED
Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under three brands, TrueImage, CoolToner, and AZtech. The company operates in North America, Europe, and Other countries.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.